Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy (Q48386144)

11 February 2018

title

Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy (English)

1 reference

11 February 2018

0 references

1 reference

Lazeyras F

1

1 reference

11 February 2018

Charles HC

2

1 reference

11 February 2018

Tupler LA

3

1 reference

11 February 2018

Erickson R

4

1 reference

11 February 2018

Boyko OB

5

1 reference

11 February 2018

Krishnan KR

6

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

11 February 2018

published in

Psychiatry Research

1 reference

11 February 2018

volume

82

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

95-106

1 reference

11 February 2018

N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

1H-MR spectroscopic imaging in patients with clinically diagnosed Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Alzheimer dementia: quantification of energy metabolism and mobile phosphoesters with P-31 NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Muscarinic mobilization of choline in rat cerebral cortex does not involve alterations of blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Muscarinic mobilization of choline in rat brain in vivo as shown by the cerebral arterio-venous difference of choline.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

In vivo 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

NMR chemical shift imaging in three dimensions

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Computed tomography in Alzheimer's disease: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Reproducibility of high spatial resolution proton magnetic resonance spectroscopic imaging in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Alzheimer's disease: longitudinal CT studies of ventricular change

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Early marker for Alzheimer's disease: the atrophic hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Inositol Lipids and Signal Transduction in the Nervous System: An Update

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Alzheimer's disease: a study of epidemiological aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Possible enzymatic causes for elevated phosphomonoesters in Alzheimer's disease brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Proton magnetic resonance spectroscopy of vascular- and Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Analysis of magnetic resonance spectra by mole percent: comparison to absolute units

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

BrainN-acetyl-l-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

On the mechanism of muscarinic hydrolysis of choline phospholipids in the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Receptor regulation of choline phospholipid hydrolysis. A novel source of diacylglycerol and phosphatidic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Regional metabolic alterations in Alzheimer's disease: an in vitro 1H NMR study of the hippocampus and cerebellum

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

In vivo proton magnetic resonance spectroscopy studies of human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Evidence for a membrane defect in Alzheimer disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Molecular insights into Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

A quantitative analysis of CT and cognitive measures in normal aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Comments on use of H-1 MR spectroscopy for diagnosis of probable Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Rapid in vivo proton shimming

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Probable Alzheimer disease: diagnosis with proton MR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

Magnetic resonance imaging of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900010-9

7 January 2021

10.1016/S0925-4927(98)00010-9

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018